VX-121/TEZ/D-IVA
Idiopathic Pulmonary Fibrosis
Clinical trials
3
Developer
Vertex Pharmaceuticals Incorporated
Overview
VX-121/TEZ/D-IVA is an agent tracked by PF-Atlas in the context of idiopathic pulmonary fibrosis. It appears in 3 tracked IPF clinical trials.
VX-121/TEZ/D-IVA clinical trials
Explore related
Medical disclaimer. This page summarizes research about VX-121/TEZ/D-IVA for information only. It is not medical advice. Verify approval status and evidence with the FDA and a pulmonologist.